Overview Artificial intelligence seems to be transforming drug discovery in 2026, enabling faster molecule design, smarter clinical trials, and reduced R&D ...

AI could review data sets to assist clinical scientists ...

Integrating "Physical Intelligence" to Accelerate Next-Gen Drug Validation and Bio-AX Revolution SANTA CLARA, CA, ...

CLEVELAND, OHIO, OH, UNITED STATES, February 24, 2026 /EINPresswire.com/ -- The Bommer Group, a life sciences-focused ...

Isomorphic Lab’s proprietary drug-discovery model is a major advance, but scientists developing open-source tools are left ...

AI boosts efficiency in early, high-failure R&D, improving success rates and capital efficiency across biotech and pharma.

"Dosing the first patient in Phase III represents a major milestone for MDR-001 and for AI-enabled drug development," said Zhangming Niu, Founder and Chief Executive Officer of MindRank. "We believe ...

And there's more than one way to monetize this technology.

Merck and Mayo Clinic are partnering to use AI technology and large-scale clinical data to speed drug development in MS and other conditions.

Nanyang Biologics Pte. Ltd., together with its subsidiaries (collectively, the "Company", "we" or "NYB"), offers a comprehensive drug discovery platform that integrates the wisdom of traditional ...

Explore the impact of AI in drug discovery as 2026 promises critical clinical results and industry transformations.

Mayo Clinic, for its part, described the collaboration as its first strategic partnership of this scale with a global ...